Capstone Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,768
Closed -$1.42M 1883
2025
Q3
$1.42M Buy
2,768
+1,405
+103% +$613K ﹤0.01% 891
2025
Q2
$428K Buy
+1,363
New +$409K ﹤0.01% 1209
2024
Q3
Sell
-1,198
Closed -$493K 2091
2024
Q2
$493K Buy
1,198
+22
+2% +$8.71K ﹤0.01% 1313
2024
Q1
$475K Buy
+1,176
New +$413K ﹤0.01% 1590
2023
Q3
Sell
-1,027
Closed -$247K 2215
2023
Q2
$247K Buy
+1,027
New +$213K ﹤0.01% 1471

Other funds holding MEDP

Capstone Investment Advisors's MEDP Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Medpace (MEDP) in Q4 2025, closing a stake of 2,768 shares — an estimated $1.42M sold.

Capstone Investment Advisors first reported a position in MEDP in Q2 2023 and held it in 5 quarters. The position peaked at $1.42M in Q3 2025. 787 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,768 Medpace shares in Q4 2025, an estimated $1.42M.
  • Capstone Investment Advisors first reported a position in Medpace in Q2 2023 and held it in 5 quarters.
  • Capstone Investment Advisors's Medpace position peaked at $1.42M in Q3 2025.
  • 787 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.